Prospective study shows efficacy of intravitreal aflibercept for RP-associated CMO
Intravitreal aflibercept proves effective in RP-CMO
LEARN MOREIntravitreal aflibercept proves effective in RP-CMO
LEARN MORESwitching to aflibercept in treatment-resistant ME secondary to RVO
LEARN MORELEAVO study compares anti-VEGF agents in vein occlusion
LEARN MOREAMA grants CPT codes for home-based OCT assessment
LEARN MOREError